Business Context and Reporting Period
Company: Rockwell Medical, Inc. (RMTI)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2026
Event: Regulation FD Disclosure regarding the release of an updated corporate presentation.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of a corporate presentation (Exhibit 99.1) and does not contain audited financial statements or specific financial data points.
Material Changes
No material changes to financial performance or operations are detailed in the text of this filing. The only reported event is the distribution of an updated corporate presentation to the public.
Guidance, Outlook, and Risks
Management Commentary: The company made an updated corporate presentation available on August 13, 2026.
Legal Disclaimer: In accordance with General Instruction B.2 of Form 8-K, the information in this report and the attached presentation is not deemed "filed" under Section 18 of the Exchange Act and is not subject to the liabilities of that section. It will not be incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Review the attached Exhibit 99.1 (Corporate Presentation dated August 13, 2026) for specific financial updates, strategic outlook, and operational metrics not included in this summary.
- Note the discrepancy between the report date (August 13, 2026) and the signature date (May 7, 2026) listed in the document text.
- Verify the trading status of Common Stock (RMTI) on the Nasdaq Capital Market.